Study sheds light on why some early-stage breast cancers progress and others do not
2 minute read | Published January 10, 2018
Medically Reviewed | Last reviewed by an MD Anderson Cancer Center medical professional on January 10, 2018
A new genetic-based model developed by an MD Anderson research team may explain how a common form of early-stage breast cancer known as ductal carcinoma in situ (DCIS) progresses to a more invasive form of cancer known as invasive ductal carcinoma (IDC).
The discovery was made possible by the researchers’ development of a new analytical tool called topographic single cell sequencing (TSCS).
“While DCIS is the most common form of early-stage breast cancer and is often detected during mammography, 10 to 30 percent of this type of cancer progresses to IDC,” said Nicholas Navin, Ph.D., associate professor of Genetics. “Exactly how DCIS invasion occurs genomically remains poorly understood due to several technical challenges in tissue analysis.”
The problem lies within the tumor itself, with cells that often have individual genetic characteristics, known as intratumor heterogeneity. Their unique cellular makeup makes treatment more difficult, while a low number of tumor cells in the breast milk ducts make the cells harder to spot due to their scarcity.
Navin’s team found that genome evolution occurs in the ducts before cancer clones can be disseminated by “breaking through” the thin layer of tissue known as the basement membrane. They found that multiple cancer cell clones co-migrate from the ducts into adjacent regions to form invasive tumors.
Previous single cell DNA sequencing methods have emerged as powerful tools for understanding intratumor heterogeneity, but they delete information about individual tumor cells’ precise location within the tissue. Cellular spatial data is critical for knowing whether tumor cells are DCIS or IDC. TSCS more accurately measures and describes specific characteristics of single tumor cells.
“Because TSCS provides spatial information on cell location, it represents a milestone over previous methods that can only use suspension of cells, therefore losing all spatial information,” said Navin.“It is our hope that this type of study will shed light on the enigmatic question of why some pre-malignant cancers do not progress while others become invasive.”
Learn more about this study in MD Anderson's newsroom.
